"Global Vaccine Adjuvant Market Overview:
Global Vaccine Adjuvant Market is expected to grow at a significant rate during the forecast period 2025-2032, with 2024 as the base year.
Global Vaccine Adjuvant Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Vaccine Adjuvant involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Vaccine Adjuvant Market:
The Vaccine Adjuvant Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Vaccine Adjuvant Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Vaccine Adjuvant Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Vaccine Adjuvant market has been segmented into:
Mineral Salt-based Adjuvant
Tensoactive Adjuvants
Adjuvant Emulsions
Liposome Adjuvants
Carbohydrate Adjuvants
Bacteria-derived Adjuvants
Virus-like Particles (VLP
By Application, Vaccine Adjuvant market has been segmented into:
Active Immunostimulants
Carriers
and Vehicle Adjuvants
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Vaccine Adjuvant market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Vaccine Adjuvant market.
Top Key Players Covered in Vaccine Adjuvant market are:
Thermo Fisher Scientific Inc.
Air Liquide (Seppic)
Pacific GeneTech Limited
OZ Biosciences
Novavax Inc.
Merck & Co. Inc.
InvivoGen
GlaxoSmithKline PLC
Dynavax Technologies Corporation
CSL Limited
Croda International PLC
Vertellus
Aphios Corporation
Agenus Inc.
Adjuvatis
Associated British Foods PLC (SPI Pharma Inc.)
among others.
"
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Vaccine Adjuvant Market by Type
4.1 Vaccine Adjuvant Market Snapshot and Growth Engine
4.2 Vaccine Adjuvant Market Overview
4.3 Mineral Salt-based Adjuvant
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Mineral Salt-based Adjuvant: Geographic Segmentation Analysis
4.4 Tensoactive Adjuvants
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Tensoactive Adjuvants: Geographic Segmentation Analysis
4.5 Adjuvant Emulsions
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Adjuvant Emulsions: Geographic Segmentation Analysis
4.6 Liposome Adjuvants
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 Liposome Adjuvants: Geographic Segmentation Analysis
4.7 Carbohydrate Adjuvants
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.7.3 Key Market Trends, Growth Factors and Opportunities
4.7.4 Carbohydrate Adjuvants: Geographic Segmentation Analysis
4.8 Bacteria-derived Adjuvants
4.8.1 Introduction and Market Overview
4.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.8.3 Key Market Trends, Growth Factors and Opportunities
4.8.4 Bacteria-derived Adjuvants: Geographic Segmentation Analysis
4.9 Virus-like Particles (VLP
4.9.1 Introduction and Market Overview
4.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.9.3 Key Market Trends, Growth Factors and Opportunities
4.9.4 Virus-like Particles (VLP: Geographic Segmentation Analysis
Chapter 5: Vaccine Adjuvant Market by Application
5.1 Vaccine Adjuvant Market Snapshot and Growth Engine
5.2 Vaccine Adjuvant Market Overview
5.3 Active Immunostimulants
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Active Immunostimulants: Geographic Segmentation Analysis
5.4 Carriers
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Carriers: Geographic Segmentation Analysis
5.5 and Vehicle Adjuvants
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 and Vehicle Adjuvants: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Vaccine Adjuvant Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 THERMO FISHER SCIENTIFIC INC.
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 AIR LIQUIDE (SEPPIC)
6.4 PACIFIC GENETECH LIMITED
6.5 OZ BIOSCIENCES
6.6 NOVAVAX INC.
6.7 MERCK & CO. INC.
6.8 INVIVOGEN
6.9 GLAXOSMITHKLINE PLC
6.10 DYNAVAX TECHNOLOGIES CORPORATION
6.11 CSL LIMITED
6.12 CRODA INTERNATIONAL PLC
6.13 VERTELLUS
6.14 APHIOS CORPORATION
6.15 AGENUS INC.
6.16 ADJUVATIS
6.17 AND ASSOCIATED BRITISH FOODS PLC (SPI PHARMA INC.)
6.18 AMONG OTHERS.
Chapter 7: Global Vaccine Adjuvant Market By Region
7.1 Overview
7.2. North America Vaccine Adjuvant Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Mineral Salt-based Adjuvant
7.2.4.2 Tensoactive Adjuvants
7.2.4.3 Adjuvant Emulsions
7.2.4.4 Liposome Adjuvants
7.2.4.5 Carbohydrate Adjuvants
7.2.4.6 Bacteria-derived Adjuvants
7.2.4.7 Virus-like Particles (VLP
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Active Immunostimulants
7.2.5.2 Carriers
7.2.5.3 and Vehicle Adjuvants
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Vaccine Adjuvant Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Mineral Salt-based Adjuvant
7.3.4.2 Tensoactive Adjuvants
7.3.4.3 Adjuvant Emulsions
7.3.4.4 Liposome Adjuvants
7.3.4.5 Carbohydrate Adjuvants
7.3.4.6 Bacteria-derived Adjuvants
7.3.4.7 Virus-like Particles (VLP
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Active Immunostimulants
7.3.5.2 Carriers
7.3.5.3 and Vehicle Adjuvants
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Vaccine Adjuvant Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Mineral Salt-based Adjuvant
7.4.4.2 Tensoactive Adjuvants
7.4.4.3 Adjuvant Emulsions
7.4.4.4 Liposome Adjuvants
7.4.4.5 Carbohydrate Adjuvants
7.4.4.6 Bacteria-derived Adjuvants
7.4.4.7 Virus-like Particles (VLP
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Active Immunostimulants
7.4.5.2 Carriers
7.4.5.3 and Vehicle Adjuvants
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Vaccine Adjuvant Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Mineral Salt-based Adjuvant
7.5.4.2 Tensoactive Adjuvants
7.5.4.3 Adjuvant Emulsions
7.5.4.4 Liposome Adjuvants
7.5.4.5 Carbohydrate Adjuvants
7.5.4.6 Bacteria-derived Adjuvants
7.5.4.7 Virus-like Particles (VLP
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Active Immunostimulants
7.5.5.2 Carriers
7.5.5.3 and Vehicle Adjuvants
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Vaccine Adjuvant Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Mineral Salt-based Adjuvant
7.6.4.2 Tensoactive Adjuvants
7.6.4.3 Adjuvant Emulsions
7.6.4.4 Liposome Adjuvants
7.6.4.5 Carbohydrate Adjuvants
7.6.4.6 Bacteria-derived Adjuvants
7.6.4.7 Virus-like Particles (VLP
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Active Immunostimulants
7.6.5.2 Carriers
7.6.5.3 and Vehicle Adjuvants
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Vaccine Adjuvant Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Mineral Salt-based Adjuvant
7.7.4.2 Tensoactive Adjuvants
7.7.4.3 Adjuvant Emulsions
7.7.4.4 Liposome Adjuvants
7.7.4.5 Carbohydrate Adjuvants
7.7.4.6 Bacteria-derived Adjuvants
7.7.4.7 Virus-like Particles (VLP
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Active Immunostimulants
7.7.5.2 Carriers
7.7.5.3 and Vehicle Adjuvants
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Vaccine Adjuvant Scope:
|
Report Data
|
Vaccine Adjuvant Market
|
|
Vaccine Adjuvant Market Size in 2025
|
USD XX million
|
|
Vaccine Adjuvant CAGR 2025 - 2032
|
XX%
|
|
Vaccine Adjuvant Base Year
|
2024
|
|
Vaccine Adjuvant Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Thermo Fisher Scientific Inc., Air Liquide (Seppic), Pacific GeneTech Limited, OZ Biosciences, Novavax Inc., Merck & Co. Inc., InvivoGen, GlaxoSmithKline PLC, Dynavax Technologies Corporation, CSL Limited, Croda International PLC, Vertellus, Aphios Corporation, Agenus Inc., Adjuvatis, and Associated British Foods PLC (SPI Pharma Inc.), among others..
|
|
Key Segments
|
By Type
Mineral Salt-based Adjuvant
Tensoactive Adjuvants
Adjuvant Emulsions
Liposome Adjuvants
Carbohydrate Adjuvants
Bacteria-derived Adjuvants
Virus-like Particles (VLP
By Applications
Active Immunostimulants
Carriers
and Vehicle Adjuvants
|
